0
Arcutis Biotherapeutics, Inc. Banner Image

Arcutis Biotherapeutics, Inc. has reached its limit for free report views

Work for Arcutis Biotherapeutics, Inc.? Upgrade Your Profile and unlock all your annual reports.

Arcutis Biotherapeutics, Inc.

  • Ticker ARQT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Arcutis Biotherapeutics, Inc. Logo Image
  • 11-50 Employees
  • Based in Westlake Village, California
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. The company is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets toMore solve persistent treatment challenges in serious diseases of the skin. Arcutis’ robust pipeline includes four novel drug candidates currently in development for a range of inflammatory dermatological conditions. The company’s lead product candidate, topical roflumilast, has the potential to revitalize the standard of care for plaque psoriasis, atopic dermatitis, scalp psoriasis, and seborrheic dermatitis.
Arcutis Biotherapeutics, Inc.

Most Recent Annual Report

Arcutis Biotherapeutics, Inc. MOST RECENT 2020 Annual Report, 2019 Form 10K

Report Locked. Arcutis Biotherapeutics, Inc. has reached its limit for free report views.

Older/Archived Annual Reports